Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Psoriasis Drugs market report explains the definition, types, applications, major countries, and major players of the Psoriasis Drugs market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Novartis
AbbVie
UCB
Amgen
Merck
AstraZeneca
Johnson & Johnson
Eli Lilly & Company
Celgene Corporation
By Type:
Tumor Necrosis Factor Inhibitor
Interleukin Inhibitors
Others
By End-User:
Topicals
Systemic
Biologics
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Psoriasis Drugs Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Psoriasis Drugs Outlook to 2028- Original Forecasts
-
2.2 Psoriasis Drugs Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Psoriasis Drugs Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Psoriasis Drugs Market- Recent Developments
-
6.1 Psoriasis Drugs Market News and Developments
-
6.2 Psoriasis Drugs Market Deals Landscape
7 Psoriasis Drugs Raw Materials and Cost Structure Analysis
-
7.1 Psoriasis Drugs Key Raw Materials
-
7.2 Psoriasis Drugs Price Trend of Key Raw Materials
-
7.3 Psoriasis Drugs Key Suppliers of Raw Materials
-
7.4 Psoriasis Drugs Market Concentration Rate of Raw Materials
-
7.5 Psoriasis Drugs Cost Structure Analysis
-
7.5.1 Psoriasis Drugs Raw Materials Analysis
-
7.5.2 Psoriasis Drugs Labor Cost Analysis
-
7.5.3 Psoriasis Drugs Manufacturing Expenses Analysis
8 Global Psoriasis Drugs Import and Export Analysis (Top 10 Countries)
-
8.1 Global Psoriasis Drugs Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Psoriasis Drugs Export by Region (Top 10 Countries) (2017-2028)
9 Global Psoriasis Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Psoriasis Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Tumor Necrosis Factor Inhibitor Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Interleukin Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Psoriasis Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Topicals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Systemic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Biologics Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Psoriasis Drugs Market Analysis and Outlook till 2022
-
10.1 Global Psoriasis Drugs Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Psoriasis Drugs Consumption (2017-2022)
-
10.2.2 Canada Psoriasis Drugs Consumption (2017-2022)
-
10.2.3 Mexico Psoriasis Drugs Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Psoriasis Drugs Consumption (2017-2022)
-
10.3.2 UK Psoriasis Drugs Consumption (2017-2022)
-
10.3.3 Spain Psoriasis Drugs Consumption (2017-2022)
-
10.3.4 Belgium Psoriasis Drugs Consumption (2017-2022)
-
10.3.5 France Psoriasis Drugs Consumption (2017-2022)
-
10.3.6 Italy Psoriasis Drugs Consumption (2017-2022)
-
10.3.7 Denmark Psoriasis Drugs Consumption (2017-2022)
-
10.3.8 Finland Psoriasis Drugs Consumption (2017-2022)
-
10.3.9 Norway Psoriasis Drugs Consumption (2017-2022)
-
10.3.10 Sweden Psoriasis Drugs Consumption (2017-2022)
-
10.3.11 Poland Psoriasis Drugs Consumption (2017-2022)
-
10.3.12 Russia Psoriasis Drugs Consumption (2017-2022)
-
10.3.13 Turkey Psoriasis Drugs Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Psoriasis Drugs Consumption (2017-2022)
-
10.4.2 Japan Psoriasis Drugs Consumption (2017-2022)
-
10.4.3 India Psoriasis Drugs Consumption (2017-2022)
-
10.4.4 South Korea Psoriasis Drugs Consumption (2017-2022)
-
10.4.5 Pakistan Psoriasis Drugs Consumption (2017-2022)
-
10.4.6 Bangladesh Psoriasis Drugs Consumption (2017-2022)
-
10.4.7 Indonesia Psoriasis Drugs Consumption (2017-2022)
-
10.4.8 Thailand Psoriasis Drugs Consumption (2017-2022)
-
10.4.9 Singapore Psoriasis Drugs Consumption (2017-2022)
-
10.4.10 Malaysia Psoriasis Drugs Consumption (2017-2022)
-
10.4.11 Philippines Psoriasis Drugs Consumption (2017-2022)
-
10.4.12 Vietnam Psoriasis Drugs Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Psoriasis Drugs Consumption (2017-2022)
-
10.5.2 Colombia Psoriasis Drugs Consumption (2017-2022)
-
10.5.3 Chile Psoriasis Drugs Consumption (2017-2022)
-
10.5.4 Argentina Psoriasis Drugs Consumption (2017-2022)
-
10.5.5 Venezuela Psoriasis Drugs Consumption (2017-2022)
-
10.5.6 Peru Psoriasis Drugs Consumption (2017-2022)
-
10.5.7 Puerto Rico Psoriasis Drugs Consumption (2017-2022)
-
10.5.8 Ecuador Psoriasis Drugs Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Psoriasis Drugs Consumption (2017-2022)
-
10.6.2 Kuwait Psoriasis Drugs Consumption (2017-2022)
-
10.6.3 Oman Psoriasis Drugs Consumption (2017-2022)
-
10.6.4 Qatar Psoriasis Drugs Consumption (2017-2022)
-
10.6.5 Saudi Arabia Psoriasis Drugs Consumption (2017-2022)
-
10.6.6 United Arab Emirates Psoriasis Drugs Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Psoriasis Drugs Consumption (2017-2022)
-
10.7.2 South Africa Psoriasis Drugs Consumption (2017-2022)
-
10.7.3 Egypt Psoriasis Drugs Consumption (2017-2022)
-
10.7.4 Algeria Psoriasis Drugs Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Psoriasis Drugs Consumption (2017-2022)
-
10.8.2 New Zealand Psoriasis Drugs Consumption (2017-2022)
11 Global Psoriasis Drugs Competitive Analysis
-
11.1 Novartis
-
11.1.1 Novartis Company Details
-
11.1.2 Novartis Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Novartis Psoriasis Drugs Main Business and Markets Served
-
11.1.4 Novartis Psoriasis Drugs Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 AbbVie
-
11.2.1 AbbVie Company Details
-
11.2.2 AbbVie Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 AbbVie Psoriasis Drugs Main Business and Markets Served
-
11.2.4 AbbVie Psoriasis Drugs Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 UCB
-
11.3.1 UCB Company Details
-
11.3.2 UCB Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 UCB Psoriasis Drugs Main Business and Markets Served
-
11.3.4 UCB Psoriasis Drugs Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Amgen
-
11.4.1 Amgen Company Details
-
11.4.2 Amgen Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Amgen Psoriasis Drugs Main Business and Markets Served
-
11.4.4 Amgen Psoriasis Drugs Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Merck
-
11.5.1 Merck Company Details
-
11.5.2 Merck Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Merck Psoriasis Drugs Main Business and Markets Served
-
11.5.4 Merck Psoriasis Drugs Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 AstraZeneca
-
11.6.1 AstraZeneca Company Details
-
11.6.2 AstraZeneca Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 AstraZeneca Psoriasis Drugs Main Business and Markets Served
-
11.6.4 AstraZeneca Psoriasis Drugs Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Johnson & Johnson
-
11.7.1 Johnson & Johnson Company Details
-
11.7.2 Johnson & Johnson Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Johnson & Johnson Psoriasis Drugs Main Business and Markets Served
-
11.7.4 Johnson & Johnson Psoriasis Drugs Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Eli Lilly & Company
-
11.8.1 Eli Lilly & Company Company Details
-
11.8.2 Eli Lilly & Company Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Eli Lilly & Company Psoriasis Drugs Main Business and Markets Served
-
11.8.4 Eli Lilly & Company Psoriasis Drugs Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Celgene Corporation
-
11.9.1 Celgene Corporation Company Details
-
11.9.2 Celgene Corporation Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Celgene Corporation Psoriasis Drugs Main Business and Markets Served
-
11.9.4 Celgene Corporation Psoriasis Drugs Product Portfolio
-
11.9.5 Recent Research and Development Strategies
12 Global Psoriasis Drugs Market Outlook by Types and Applications to 2028
-
12.1 Global Psoriasis Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Tumor Necrosis Factor Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Interleukin Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Psoriasis Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Topicals Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Systemic Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Biologics Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Psoriasis Drugs Market Analysis and Outlook to 2028
-
13.1 Global Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.2.2 Canada Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.2.3 Mexico Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.3.2 UK Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.3.3 Spain Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.3.4 Belgium Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.3.5 France Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.3.6 Italy Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.3.7 Denmark Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.3.8 Finland Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.3.9 Norway Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.3.10 Sweden Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.3.11 Poland Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.3.12 Russia Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.3.13 Turkey Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.4.2 Japan Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.4.3 India Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.4.4 South Korea Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.4.8 Thailand Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.4.9 Singapore Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.4.11 Philippines Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.5.2 Colombia Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.5.3 Chile Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.5.4 Argentina Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.5.6 Peru Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.6.3 Oman Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.6.4 Qatar Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.7.2 South Africa Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.7.3 Egypt Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.7.4 Algeria Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Psoriasis Drugs Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Psoriasis Drugs Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Psoriasis Drugs
-
Figure of Psoriasis Drugs Picture
-
Table Global Psoriasis Drugs Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Psoriasis Drugs Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Tumor Necrosis Factor Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Global Interleukin Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Topicals Consumption and Growth Rate (2017-2022)
-
Figure Global Systemic Consumption and Growth Rate (2017-2022)
-
Figure Global Biologics Consumption and Growth Rate (2017-2022)
-
Figure Global Psoriasis Drugs Consumption by Country (2017-2022)
-
Table North America Psoriasis Drugs Consumption by Country (2017-2022)
-
Figure United States Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Canada Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Mexico Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Psoriasis Drugs Consumption by Country (2017-2022)
-
Figure Germany Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure UK Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Spain Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Belgium Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure France Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Italy Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Denmark Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Finland Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Norway Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Sweden Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Poland Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Russia Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Turkey Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Table APAC Psoriasis Drugs Consumption by Country (2017-2022)
-
Figure China Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Thailand Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Singapore Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Philippines Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Table South America Psoriasis Drugs Consumption by Country (2017-2022)
-
Figure Brazil Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Colombia Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Chile Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Argentina Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Peru Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Table GCC Psoriasis Drugs Consumption by Country (2017-2022)
-
Figure Bahrain Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Oman Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Qatar Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Table Africa Psoriasis Drugs Consumption by Country (2017-2022)
-
Figure Nigeria Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Africa Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Egypt Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Algeria Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Table Oceania Psoriasis Drugs Consumption by Country (2017-2022)
-
Figure Australia Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Table Novartis Company Details
-
Table Novartis Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Psoriasis Drugs Main Business and Markets Served
-
Table Novartis Psoriasis Drugs Product Portfolio
-
Table AbbVie Company Details
-
Table AbbVie Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Psoriasis Drugs Main Business and Markets Served
-
Table AbbVie Psoriasis Drugs Product Portfolio
-
Table UCB Company Details
-
Table UCB Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table UCB Psoriasis Drugs Main Business and Markets Served
-
Table UCB Psoriasis Drugs Product Portfolio
-
Table Amgen Company Details
-
Table Amgen Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Psoriasis Drugs Main Business and Markets Served
-
Table Amgen Psoriasis Drugs Product Portfolio
-
Table Merck Company Details
-
Table Merck Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Psoriasis Drugs Main Business and Markets Served
-
Table Merck Psoriasis Drugs Product Portfolio
-
Table AstraZeneca Company Details
-
Table AstraZeneca Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Psoriasis Drugs Main Business and Markets Served
-
Table AstraZeneca Psoriasis Drugs Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Psoriasis Drugs Main Business and Markets Served
-
Table Johnson & Johnson Psoriasis Drugs Product Portfolio
-
Table Eli Lilly & Company Company Details
-
Table Eli Lilly & Company Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly & Company Psoriasis Drugs Main Business and Markets Served
-
Table Eli Lilly & Company Psoriasis Drugs Product Portfolio
-
Table Celgene Corporation Company Details
-
Table Celgene Corporation Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Corporation Psoriasis Drugs Main Business and Markets Served
-
Table Celgene Corporation Psoriasis Drugs Product Portfolio
-
Figure Global Tumor Necrosis Factor Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Interleukin Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Topicals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Systemic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biologics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Psoriasis Drugs Consumption Forecast by Country (2022-2028)
-
Table North America Psoriasis Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Psoriasis Drugs Consumption Forecast by Country (2022-2028)
-
Figure Germany Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Psoriasis Drugs Consumption Forecast by Country (2022-2028)
-
Figure China Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Psoriasis Drugs Consumption Forecast by Country (2022-2028)
-
Figure Brazil Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Psoriasis Drugs Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Psoriasis Drugs Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Psoriasis Drugs Consumption Forecast by Country (2022-2028)
-
Figure Australia Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
